Madan Ajay 5
5 · Crinetics Pharmaceuticals, Inc. · Filed Feb 4, 2022
Insider Transaction Report
Form 5
Madan Ajay
Chief Development Officer
Transactions
- Other
Common Stock
2021-11-19$11.02/sh+785$8,651→ 185,456 total
Footnotes (1)
- [F1]Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).